
Gujarat Terce Laboratories Ltd Upgraded to Sell on Improved Financial and Valuation Metrics
2026-06-02 08:58:56Gujarat Terce Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 1 June 2026, reflecting notable improvements in its financial trend and valuation metrics, alongside a mild easing in technical bearishness. Despite persistent challenges in sales growth and market performance, the company’s enhanced profitability and attractive valuation multiples have prompted a reassessment of its outlook by analysts.
Read full news article
Gujarat Terce Laboratories Ltd Valuation Shifts to Very Attractive Amid Sector Challenges
2026-06-02 08:04:03Gujarat Terce Laboratories Ltd has witnessed a significant improvement in its valuation parameters, shifting from a previously very expensive rating to a very attractive one. This change comes despite the company’s recent underperformance relative to the Sensex and peers in the Pharmaceuticals & Biotechnology sector, highlighting a compelling opportunity for investors to reassess the stock’s price attractiveness based on its current financial metrics and market positioning.
Read full news articleWhen is the next results date for Gujarat Terce Laboratories Ltd?
2026-05-27 23:17:20The next results date for Gujarat Terce Laboratories Ltd is scheduled for 29 May 2026....
Read full news articleWhen is the next results date for Gujarat Terce Laboratories Ltd?
2026-05-14 23:16:54The next results date for Gujarat Terce Laboratories Ltd is scheduled for 27 May 2026....
Read full news article
Gujarat Terce Laboratories Ltd is Rated Strong Sell
2026-05-14 10:10:32Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Gujarat Terce Laboratories Ltd is Rated Strong Sell
2026-04-30 10:10:38Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Gujarat Terce Laboratories Ltd is Rated Strong Sell
2026-04-16 10:10:16Gujarat Terce Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Five Consecutive Losses Push Gujarat Terce Laboratories Ltd to a New 52-Week Low
2026-03-30 15:16:06For the fifth consecutive session, Gujarat Terce Laboratories Ltd closed lower, slipping to a fresh 52-week low of Rs 29 on 30 Mar 2026. This marks a steep 21.11% decline over the past five days amid heightened volatility and persistent selling pressure.
Read full news article
Markets Rally, But Gujarat Terce Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
2026-03-27 11:47:48Despite a broader market rally, Gujarat Terce Laboratories Ltd has plunged to a fresh 52-week low of Rs 33 on 27 Mar 2026, marking a steep 43.45% decline over the past year and underscoring persistent headwinds for this micro-cap pharmaceutical player.
Read full news articleAmendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
01-Jun-2026 | Source : BSEThe amended code is enclosed.
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSECopy of the newspaper publication for the financial results for the year ended 31 March 2026.
Fixation Of Date Of 41St Annual General Meeting (AGM) Of The Company For The Financial Year Ended 31 March 2026 To Be Held On Friday 21 August 2026
30-May-2026 | Source : BSEDetailed disclosure is attached
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






